Seicean Andreea, Alan Nima, Seicean Sinziana, Neuhauser Duncan, Selman Warren R, Bambakidis Nicholas C
Case Western Reserve University School of Medicine;
Department of Epidemiology and Biostatistics, Case Western Reserve University;
J Neurosurg. 2015 Jul;123(1):91-100. doi: 10.3171/2014.10.JNS14551. Epub 2015 Apr 10.
Preoperative anemia may be treated with a blood transfusion. Both are associated with adverse outcomes in various surgical procedures, but this has not been clearly elucidated in surgery for cerebral aneurysms. In this study the authors assessed the association of preoperative anemia and perioperative blood transfusion, separately, on 30-day morbidity and mortality in patients undergoing open surgery for ruptured and unruptured intracranial aneurysms.
The authors identified 668 cases (including 400 unruptured and 268 unruptured intracranial aneurysms) of open surgery for treatment of intracranial aneurysms in the 2006-2012 National Surgical Quality Improvement Program, a validated and reproducible prospective clinical database. Anemia was defined as a hematocrit level less than 39% in males and less than 36% in females. Perioperative transfusion was defined as at least 1 unit of packed or whole red blood cells given at any point between the start of surgery to 72 hours postoperatively. The authors separately compared surgical outcome between patients with (n = 198) versus without (n = 470) anemia, and those who underwent (n = 78) versus those who did not receive (n = 521) a transfusion, using a 1:1 match on propensity score.
In the matched cohorts, all observed covariates were comparable between anemic (n = 147) versus nonanemic (n = 147) and between transfused (n = 67) versus nontransfused patients (n = 67). Anemia was independently associated with prolonged hospital length of stay (LOS; odds ratio [OR] 2.5, 95% confidence interval [CI] 1.4-4.5), perioperative complications (OR 1.9, 95% CI 1.1-3.1), and return to the operating room (OR 2.1, 95% CI 1.1-4.5). Transfusion was also independently associated with perioperative complications (OR 2.4, 95% CI 1.1-5.3).
Preoperative anemia and transfusion are each independent risk factors for perioperative complications in patients undergoing surgery for cerebral aneurysms. Perioperative anemia is also associated with prolonged hospital LOS and 30-day return to the operating room.
术前贫血可能需输血治疗。二者在各类外科手术中均与不良预后相关,但在脑动脉瘤手术中尚未明确阐明。在本研究中,作者分别评估了术前贫血和围手术期输血与接受开颅手术治疗破裂和未破裂颅内动脉瘤患者30天发病率及死亡率的关联。
作者在2006 - 2012年国家外科质量改进计划(一个经过验证且可重复的前瞻性临床数据库)中确定了668例开颅手术治疗颅内动脉瘤的病例(包括400例未破裂和268例破裂颅内动脉瘤)。贫血定义为男性血细胞比容水平低于39%,女性低于36%。围手术期输血定义为在手术开始至术后72小时内的任何时间给予至少1单位浓缩红细胞或全血红细胞。作者使用倾向评分1:1匹配,分别比较了有贫血(n = 198)与无贫血(n = 470)患者以及接受输血(n = 78)与未接受输血(n = 521)患者的手术结果。
在匹配队列中,所有观察到的协变量在贫血患者(n = 147)与非贫血患者(n = 147)之间以及输血患者(n = 67)与未输血患者(n = 67)之间具有可比性。贫血与住院时间延长(LOS;优势比[OR] 2.5,95%置信区间[CI] 1.4 - 4.5)、围手术期并发症(OR 1.9,95% CI 1.1 - 3.1)以及返回手术室(OR 2.1,95% CI 1.1 - 4.5)独立相关。输血也与围手术期并发症独立相关(OR 2.4,95% CI 1.1 - 5.3)。
术前贫血和输血均是脑动脉瘤手术患者围手术期并发症的独立危险因素。围手术期贫血还与住院时间延长及30天返回手术室相关。